Bioinformatics studies of gliomas have an important role in improving the accuracy of diagnosis and treatment, for example, thanks to bioinformatics, WHO have added molecular biomarkers such as isocitrate dehydrogenase mutation status to the diagnostic guidelines of glioma (Louis et al., 2016). The gene discussed is IDH3A; the disease is glioma.